These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cancer-associated fibroblast exosome LINC00355 promotes epithelial-mesenchymal transition and chemoresistance in colorectal cancer through the miR-34b-5p/CRKL axis. Hu JH, Tang HN, Wang YH. Cancer Gene Ther; 2024 Feb; 31(2):259-272. PubMed ID: 38052858 [Abstract] [Full Text] [Related]
4. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19. Ren J, Ding L, Zhang D, Shi G, Xu Q, Shen S, Wang Y, Wang T, Hou Y. Theranostics; 2018 Feb; 8(14):3932-3948. PubMed ID: 30083271 [Abstract] [Full Text] [Related]
5. Oxaliplatin inhibits colorectal cancer progression by inhibiting CXCL11 secreted by cancer-associated fibroblasts and the CXCR3/PI3K/AKT pathway. Lu C, Zhang C. Clin Transl Oncol; 2023 Jan; 25(1):160-172. PubMed ID: 36129606 [Abstract] [Full Text] [Related]
9. Cancer-associated fibroblasts-derived exosome-mediated transfer of miR-345-5p promotes the progression of colorectal cancer by targeting CDKN1A. Shi W, Liu Y, Qiu X, Yang L, Lin G. Carcinogenesis; 2023 Jun 24; 44(4):317-327. PubMed ID: 37052230 [Abstract] [Full Text] [Related]
11. Sanguinarine inhibits epithelial ovarian cancer development via regulating long non-coding RNA CASC2-EIF4A3 axis and/or inhibiting NF-κB signaling or PI3K/AKT/mTOR pathway. Zhang S, Leng T, Zhang Q, Zhao Q, Nie X, Yang L. Biomed Pharmacother; 2018 Jun 24; 102():302-308. PubMed ID: 29571014 [Abstract] [Full Text] [Related]
19. EIF4A3-induced circ_0084615 contributes to the progression of colorectal cancer via miR-599/ONECUT2 pathway. Jiang Z, Tai Q, Xie X, Hou Z, Liu W, Yu Z, Liang Z, Chen S. J Exp Clin Cancer Res; 2021 Jul 12; 40(1):227. PubMed ID: 34253241 [Abstract] [Full Text] [Related]